TOI
TOI
NASDAQ · Health Care

Oncology Institute Inc/The

$2.96
-0.14 (-4.52%)
As of Mar 29, 10:32 PM ET ·
Financial Highlights (FY 2026)
Revenue
528.74M
Net Income
-86,909,822
Gross Margin
13.7%
Profit Margin
-16.4%
Rev Growth
+24.7%
D/E Ratio
25.95
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 13.7% 13.7% 54.9% 54.9%
Operating Margin -15.3% -13.8% 16.6% 15.3%
Profit Margin -16.4% -15.6% 14.5% 15.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 528.74M 424.08M 77.47M 69.37M
Gross Profit 72.60M 58.23M 42.55M 38.11M
Operating Income -80,791,612 -58,319,257 12.86M 10.62M
Net Income -86,909,822 -62,735,675 11.21M 10.99M
Gross Margin 13.7% 13.7% 54.9% 54.9%
Operating Margin -15.3% -13.8% 16.6% 15.3%
Profit Margin -16.4% -15.6% 14.5% 15.8%
Rev Growth +24.7% +24.7% +0.6% -2.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 134.99M 134.99M 66.92M 74.82M
Total Equity 5.20M 5.20M 141.02M 147.52M
D/E Ratio 25.95 25.95 0.47 0.51
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -69,219,230 -52,741,633 16.24M 13.18M
Free Cash Flow 11.97M 11.86M